Skip to Main Content

Paper Details

Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus-Associated Gastric Adenocarcinoma With ERBB2 Amplification.
JCO Precis Oncol
2
2021
Author NameAffiliation
Joanna CyrtaInstitut Curie, PSL Research University
Julien Masliah-PlanchonInstitut Curie, PSL Research University
  • 1 - 2

Datasets

Release 1.2